FDA Accepts for Review BLA for DMB-3115 of Dong-A ST, a Proposed Biosimilar to Stelara® (Ustekinumab)
- Following EMA, FDA accepted BLA for DMB-3115 SEOUL, South Korea--(BUSINESS WIRE)--#AccordBiopharma--Dong-A ST (President/CEO Min-young…
- Following EMA, FDA accepted BLA for DMB-3115 SEOUL, South Korea--(BUSINESS WIRE)--#AccordBiopharma--Dong-A ST (President/CEO Min-young…
SAN JOSE, Calif.--(BUSINESS WIRE)--#ADAS--Omni Design Technologies, a leading provider of high-performance, low-power mixed-signal intellectual property…
Enrolled first PH-ILD patient in the open-label ASCENT study of YUTREPIA Confirmed with FDA that…
TOKUSHIMA, Japan--(BUSINESS WIRE)--Following the previous information on June 30th in 2023, we are excited to…
Projection Mapping Light Show and Stage Event were Performed TOKYO--(BUSINESS WIRE)--#HAPPYNEWYEARTOKYO--In order to see off…
TAIPEI, Taiwan--(BUSINESS WIRE)--United Microelectronics Corporation (NYSE: UMC; TWSE: 2303) (“UMCâ€), today reported unaudited net sales…
KUALA LUMPUR, Malaysia--(BUSINESS WIRE)--The Federation of Chinese Associations Malaysia (HUAZONG) proudly announces the appointment of…
BOSTON--(BUSINESS WIRE)--American Tower Corporation (NYSE: AMT) (“American Towerâ€) has signed a definitive agreement with Data…
HONG KONG--(BUSINESS WIRE)--The Chinese New Year is always associated with a form of archaic or…
Autonomous Mobile Robot (AMR) "Rally" On Display at World Class Retail Conference NRF 2024: Retail's…